Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Long-term (>= 8 years) outcome after Plamaz-Schatz stent implantation
Autore:
Choussat, R; Klersy, C; Black, AJR; Bossi, I; Laurent, JP; Jordan, C; Guagliumi, G; Fajadet, J; Marco, J;
Indirizzi:
Clin Pasteur, Unite Cardiol Intervent, F-31076 Toulouse, France Clin Pasteur Toulouse France F-31076 Intervent, F-31076 Toulouse, France IRCCS, Policlin San Matteo, Biometry Res Management Dept, Pavia, Italy IRCCS Pavia Italy an Matteo, Biometry Res Management Dept, Pavia, Italy Geelong Hosp, Dept Cardiol, Geelong, Vic, Australia Geelong Hosp Geelong Vic Australia Dept Cardiol, Geelong, Vic, Australia
Titolo Testata:
AMERICAN JOURNAL OF CARDIOLOGY
fascicolo: 1, volume: 88, anno: 2001,
pagine: 10 - 16
SICI:
0002-9149(20010701)88:1<10:L(8YOA>2.0.ZU;2-5
Fonte:
ISI
Lingua:
ENG
Soggetto:
CLINICAL FOLLOW-UP; BALLOON-EXPANDABLE-STENT; SINGLE-CENTER EXPERIENCE; CORONARY-ARTERY DISEASE; DIABETES-MELLITUS; ANGIOPLASTY; RESTENOSIS; PLACEMENT; MULTICENTER; CLOSURE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
30
Recensione:
Indirizzi per estratti:
Indirizzo: Fajadet, J Clin Pasteur, Unite Cardiol Intervent, 45 Ave Lombez, F-31076 Toulouse, France Clin Pasteur 45 Ave Lombez Toulouse France F-31076 use, France
Citazione:
R. Choussat et al., "Long-term (>= 8 years) outcome after Plamaz-Schatz stent implantation", AM J CARD, 88(1), 2001, pp. 10-16

Abstract

The purpose of this single-center study was to evaluate the long-term (greater than or equal to8 years) outcome of Palmaz-Schatz infracoronary stenting and to identify independent predictors of outcome. Although short-term results of Palmaz-Schatz intracoronary stenting have been promising, with a reduction in both angiographic restenosis and clinical cardiac events vp to3 years, longer-term follow-up has not been established. We analyzed clinical outcome ire 426 consecutive patients at least 8 years after coronary stenting. Demographic, clinical, and procedural predictors Of restenosis, survival, and event-free survival, defined as freedom from death, myocardial infarction(MI), and coronary revascularization (target stented site, target vessel: and any revascularization) were analyzed. Before discharge, 28 patients (6.6%) sustained at least 1 major cardiovascular event: 3 deaths (0.7%), 18 Mls (4.2%), and 17 repeat revascularizations. Surviving patients werefollowed for 8.9 years (interquartile range 8.4 to 9.4). After discharge, 59 patients (13.9%) died, 47 (11.1%) sustained an MI, and 188 (44.4%) underwent coronary revascularization. The 8-year event-free survival (freedom from death, freedom from death/MI/target-stented site revascularization, and freedom from death/MI/any coronary revascularization) was (mean +/- SE) 0.86 +/- 0.01, 0.62 +/- 0.03, and 0.47 +/- 0.02, respectively. Unstable angina, lower left ventricular ejection fraction, and saphenous vein graft stenting were found to be independent predictors of death during follow-up. Hypertension, unstable angina, multivessel disease, and multiple stent implantation were found to be independent predictors of the composite of death/MI/any coronary revascularization during follow-vp. This study provided a usefulassessment of very longterm outcome in survival, event-free survival, and predictors of major cardiac events 8 to 10 years after Palmaz-Schatz stent implantation. (C) 2001 by Excerpta Medica, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/04/20 alle ore 12:16:14